Compare · BSX vs SOLY
BSX vs SOLY
Side-by-side comparison of Boston Scientific Corporation (BSX) and Soliton, Inc. (SOLY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BSX and SOLY operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BSX is the larger of the two at $72.39B, about 161.0x SOLY ($449.6M).
- BSX has hit the wire 12 times in the past 4 weeks while SOLY has been quiet.
- BSX has more recent analyst coverage (25 ratings vs 0 for SOLY).
- Company
- Boston Scientific Corporation
- Soliton, Inc.
- Price
- $48.71+0.31%
- $22.59+0.16%
- Market cap
- $72.39B
- $449.6M
- 1M return
- -13.91%
- -
- 1Y return
- -51.31%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 12
- 0
- Recent ratings
- 25
- 0
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Soliton, Inc.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas.
Latest BSX
- Chairman, President & CEO Mahoney Michael F gifted 386,755 shares (SEC Form 4)
- Boston Scientific downgraded by Wolfe Research
- Boston Scientific downgraded by Wells Fargo with a new price target
- Director Ludwig Edward J bought $202,914 worth of shares (3,580 units at $56.68), increasing direct ownership by 16% to 25,359 units (SEC Form 4)
- Director Pegus Cheryl bought $99,987 worth of shares (1,770 units at $56.49) (SEC Form 4)
- Director Habiger David C bought $251,098 worth of shares (4,450 units at $56.43), increasing direct ownership by 47% to 13,878 units (SEC Form 4)
- SEC Form SD filed by Boston Scientific Corporation
- FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints
- Boston Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Boston Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest SOLY
- SEC Form 15-12B filed by Soliton, Inc.
- SEC Form EFFECT filed by Soliton, Inc.
- SEC Form EFFECT filed by Soliton, Inc.
- SEC Form EFFECT filed by Soliton, Inc.
- SEC Form SC 13D/A filed by Soliton, Inc. (Amendment)
- SEC Form 4: Remeditex Ventures Llc returned $208,242,660 worth of shares to the company (9,214,277 units at $22.60)
- SEC Form 4: Tanner Joe D returned $1,808,000 worth of shares to the company (80,000 units at $22.60), closing all direct ownership in the company
- SEC Form 4: Klemp Walter V returned $9,605,000 worth of shares to the company (425,000 units at $22.60), closing all direct ownership in the company
- SEC Form 4 filed by Kaminer Michael S.
- SEC Form 4 filed by Hunt Niquette L.